5-HYDROXYTRYPTAMINE-INDUCED CONTRACTIONS OF THE HUMAN ISOLATED SAPHENOUS-VEIN - INVOLVEMENT OF 5-HT2 AND 5-HT1D-LIKE RECEPTORS, AND A COMPARISON WITH GRAFTED VEINS

被引:47
|
作者
BAX, WA
VANHEUVENNOLSEN, D
BOS, E
SIMOONS, ML
SAXENA, PR
机构
[1] ERASMUS UNIV, FAC MED & HLTH SCI, CTR THORAX, 3000 DR ROTTERDAM, NETHERLANDS
[2] UNIV UTRECHT, FAC PHARM, DEPT PHARMACOL, 3508 TB UTRECHT, NETHERLANDS
关键词
BYPASS; CORONARY BYPASS; 5-HT RECEPTORS; 5-HT1D RECEPTOR; 5-HT2; RECEPTOR; 5-HYDROXYTRYPTAMINE; HUMAN SAPHENOUS VEIN; SUMATRIPTAN;
D O I
10.1007/BF00168940
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The receptors mediating the contractile effect of 5-hydroxytryptamine (5-HT) on the human isolated saphenous vein, obtained from 42 patients undergoing coronary bypass surgery, have been further characterized using a number of 5-HT-related drugs. The rank order of agonist potency was 5-carboxamidotryptamine (5-CT) almost-equal-to 5-HT > methysergide almost-equal-to sumatriptan almost-equal-to alpha-methyl-5-HT almost-equal-to 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indolesuccinate (RU 24969) almost-equal-to 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI) > 2-methyl-5-HT > 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT). Flesinoxan was inactive as an agonist. Ketanserin (1-mu-mol/l) hardly affected sumatriptan-induced contractions but it caused a rightward shift of the upper part of the concentration-response curve of 5-HT and 5-CT. The same concentration of ketanserin caused a parallel rightward shift of the concentration-response curves of alpha-methyl-5-HT and DOI with pK(B) values of 7.1 and 7.1, respectively. The responses to sumatriptan were antagonized by methiothepin (0.1-mu-mol/l), metergoline (0.1 and 1-mu-mol/l), rauwolscine (1-mu-mol/l) and cyanopindolol (1-mu-mol/l); the calculated pK(B) values were 7.3, 6.9, 7.3, 6.7 and 6.5, respectively. Contractions to 5-HT were antagonized by methysergide (1-mu-mol/l), methiothepin (0.1-mu-mol/l; pK(B) = 7.1), ICS 205-930 (1-mu-mol/l; pK(B) = 5.9) and flesinoxan (30-mu-mol/l; pK(B) = 5.3). Remarkably, the contractions elicited by 2-methyl-5-HT were not attenuated by ICS 205-930, but were antagonized by methiothepin (0.1-mu-mol/l) and, more markedly, by ketanserin (1-mu-mol/l). There was a high correlation between the functional pD2 values of 5-HT1-like receptor agonists (5-CT, 5-HT, methysergide, sumatriptan, RU 24969 and 8-OH-DPAT) and their reported binding affinities for the 5-HT1D receptor in human or calf brain membranes. Such a correlation for the antagonism of sumatriptan-induced responses was less marked than for the agonists, but of the 5-HT1-like receptor subtypes it was the highest for the 5-HT1D receptor identified in human or calf brain membranes. In 3 patients, undergoing heart transplantation, saphenous vein which had previously functioned as a graft for 6-11 years, was dissected out from the heart. Though the contractions to potassium were significantly smaller in the grafted veins, the pD2 and E(max) values (calculated as percentage of potassium-induced contractions) for 5-HT and sumatriptan were similar to those found in the veins obtained directly from the lower leg. It is concluded that contractions in the human isolated saphenous vein induced by 5-HT are mediated by 5-HT2 receptors as well as by a 5-HT1-like receptor resembling the 5-HT1D subtype found in brain membranes. It is also to be noted that 2-methyl-5-HT, considered selective for the 5-HT3 receptor, contracts the saphenous vein mainly via 5-HT2 receptors.
引用
收藏
页码:500 / 508
页数:9
相关论文
共 44 条
  • [1] 5-HT1-LIKE RECEPTORS MEDIATE CONTRACTIONS OF THE RABBIT SAPHENOUS-VEIN
    VANHEUVENNOLSEN, D
    KLASEN, THMT
    LUO, QF
    SAXENA, PR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 191 (03) : 375 - 382
  • [2] 5-HT1-LIKE AND 5-HT2A RECEPTORS MEDIATE 5-HYDROXYTRYPTAMINE-INDUCED CONTRACTION OF RABBIT ISOLATED MESENTERIC-ARTERY
    YILDIZ, O
    TUNCER, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 352 (02) : 127 - 131
  • [3] VARIABLE PARTICIPATION OF 5-HT1-LIKE RECEPTORS AND 5-HT2 RECEPTORS IN SEROTONIN-INDUCED CONTRACTION OF HUMAN - ISOLATED CORONARY-ARTERIES 5-HT1-LIKE RECEPTORS RESEMBLE CLONED 5-HT1D-BETA RECEPTORS
    KAUMANN, AJ
    FRENKEN, M
    POSIVAL, H
    BROWN, AM
    CIRCULATION, 1994, 90 (03) : 1141 - 1153
  • [4] MEDIATION BY 5-HT1D RECEPTORS OF 5-HYDROXYTRYPTAMINE-INDUCED CONTRACTIONS OF RABBIT MIDDLE AND POSTERIOR CEREBRAL-ARTERIES
    DECKERT, V
    PRUNEAU, D
    ELGHOZI, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) : 939 - 945
  • [5] 5-hydroxytryptamine-induced contraction of the marmoset aorta is mediated by a 5-HT1-like receptor
    Dyer, SM
    de la Lande, IS
    Frewin, DB
    Head, RJ
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (3-4) : 246 - 251
  • [6] INVOLVEMENT OF 5-HT1, 5-HT2, AND 5-HT3 RECEPTORS IN THE MEDIATION OF THE PROLACTIN RESPONSE TO SEROTONIN AND 5-HYDROXYTRYPTOPHAN
    JORGENSEN, H
    KNIGGE, U
    WARBERG, J
    NEUROENDOCRINOLOGY, 1992, 55 (03) : 336 - 343
  • [7] Evidence for the involvement of 5-HT4 receptors in the 5-hydroxytryptamine-induced pattern of migrating myoelectric complex in sheep
    Plaza, MA
    Arruebo, MP
    Murillo, MD
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (06) : 1144 - 1150
  • [8] Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs
    Verheggen, R
    Freudenthaler, S
    MeyerDulheuer, F
    Kaumann, AJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (02) : 283 - 292
  • [9] Involvement of serotonin receptors 5-HT1 and 5-HT2 in 12(S)-HPETE-induced scratching in mice
    Kim, Dae-Kwon
    Kim, Hyoung-June
    Kim, Hyuk
    Koh, Jae-Young
    Kim, Kwang-Mi
    Noh, Min-Soo
    Kim, Jung-Ju
    Lee, Chang-Hoon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) : 390 - 394
  • [10] Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT1D-like receptor
    Shaw, AM
    Bunton, DC
    Brown, T
    Irvine, J
    MacDonald, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (01) : 69 - 82